In turn, we found that CCND1 and cyclin E1 (CCNE1) accumulate upon palbociclib treatment and that CCNE1 overexpression is sufficient to induce palbociclib resistance in HNSCC cells. This evidence concerns the gene CCNE1 and head and neck squamous cell carcinoma.